November 5, 2007 - New data released today at the American Heart Association's Scientific Sessions showed that Abbott's SIMCOR, an investigational, fixed-dose combination of Abbott's proprietary extended-release niacin, Niaspan, and simvastatin, met its primary endpoint of lowering plaque-promoting non-HDL cholesterol (total cholesterol minus HDL), while demonstrating improvements on other key lip

November 5, 2007 - Pinyons Medical Technology announced it received FDA clearance to market the PowrSyringe Injector, a ...

November 5, 2007 - According to late-breaking clinical trial results presented at the American Heart Association’s ...

November 5, 2007 - A pooled analysis of the E-SIRIUS and C-SIRIUS trials, called New SIRIUS, found that the CYPHER sirolimus-eluting coronary stent continued to provide clinical benefits with similar safety compared to a bare metal stent at five-year follow-up, according to data presented at the American Heart Association Scientific Session 2007.

November 4, 2007 – Single photon emission computed tomography (SPECT) can identify which patients will benefit more from undergoing percutaneous coronary intervention (PCI) than receiving medical therapy alone for blocked coronary arteries, according to late-breaking clinical trial results presented at the American Heart Association’s Scientific Sessions 2007.

November 4, 2007 – A specific way of dosing eptifibatide appears equally effective as giving abciximab as an adjunct to ...

November 4, 2007 – Drug-eluting stents to open blocked coronary arteries caused no more risks for death or heart attack than bare metal stents, according to a late-breaking outcomes trial presented at the American Heart Association’s Scientific Sessions 2007.